BOULE DIAGNOSTICS
Boule is a diagnostic company that develops, manufactures and sells systems and consumer products for hematology to non-institutional healthcare. Sales are carried out through a world wide network of distributors, covering more than 100 countries. The company focuses primarily on small and midsize hospitals, clinics and laboratories in non-institutional healthcare, as well as other diagnostic companies in both human and veterinary hematology. Operations are conducted through commercial subsidiar... ies in Sweden, the US and China. The business was founded in 1992 with the acquisition of Karo Bio Diagnostics AB. But the company’s history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell counter. This is an early predecessor of today’s instruments from Boule. The founders of Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., (CDS) has a similar history from Coulter Corporation which developed the world’s first blood cell counter.
BOULE DIAGNOSTICS
Industry:
Health Care Health Diagnostics Manufacturing Medical Device
Founded:
1992-01-01
Status:
Active
Contact:
+46 8 7447700
Email Addresses:
[email protected]
Total Funding:
50 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving Apache Global Site Tag
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Soundbite Medical Solutions
Soundbite is a medical device company developing products in the field of vessel preparation for management and treatment.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Boule Diagnostics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-12-14 | Biosurfit | Boule Diagnostics investment in Series A - Biosurfit | 10 M EUR |
More informations about "Boule Diagnostics"
Organisation - Boule
Boule Diagnostics AB (publ) (“Boule”) uses cookies and similar technologies (jointly called “cookies”) which are text files placed on your computer, to collect standard Internet log …See details»
Boule Diagnostics - Crunchbase Investor Profile & Investments
Boule is a diagnostic company that develops, manufactures and sells systems and consumer products for hematology to non-institutional healthcare. Sales are carried out through a world …See details»
Year-end Report Q4 2021 - Boule Diagnostics AB
Boule Diagnostics AB (publ) is a global diagnostics company specializing in near-patient, decentralized blood diagnostics and one of the few companies in the global diagnostics market …See details»
Boule Diagnostics AB - LinkedIn
Boule Diagnostics AB | 6,538 followers on LinkedIn. Improving health for everyone, everywhere -We develop and manufacture diagnostic instruments and consumables worldwide | Boule …See details»
Boule Diagnostics AB: Contact Details and Business Profile
The NAICS codes for Boule Diagnostics AB are [325998, 33, 32599, 325, 3259, 32]. What is the SIC code for Boule Diagnostics AB? The SIC codes for Boule Diagnostics AB are [38, 28]. Top …See details»
Bringing hematology testing to the point of care - Boule
Ernst Westman, former CEO of Boule Diagnostics, met Andrew in 2003, and a consumables development projects for Boule’s early hematology analyzers was initiated. In 2004, CDS was acquired by Boule Diagnostics to further enhance …See details»
Boule - Healthcare Technologies
Boule is a global diagnostics company specialized on decentralized blood diagnostics. Our history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell …See details»
Boule Diagnostics | BOUL - financialreports.eu
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized …See details»
Boule Diagnostics - Manufacturer Of Diagnostic Instruments And ...
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized …See details»
Boule Diagnostics Company Profile - Office Locations ... - Craft
Jun 20, 2024 Boule Diagnostics has 5 employees across 3 locations and kr548.09 m in annual revenue in FY 2022. See insights on Boule Diagnostics including office locations, competitors, …See details»
Boule Diagnostics : appoints David Metrena to lead US commercial ...
Jun 2, 2022 Boule Diagnostics AB is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company …See details»
About us - Boule
Boule is a global diagnostics company specialized on decentralized blood diagnostics. Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one …See details»
Laboratory diagnostic testing - Boule
Boule Diagnostics AB (publ) (“Boule”) uses cookies and similar technologies (jointly called “cookies”) which are text files placed on your computer, to collect standard Internet log …See details»
Boule Diagnostics AB - Cision News
Boule Diagnostics interim report Q3 2024 Fri, Oct 25, 2024 08:00 CET. Strong improvement in profitability Quarter July - September 2024 · Net sales amounted to SEK 130.4 million (139.6), …See details»
Interim report Q2 2022 - Boule
Boule Diagnostics AB (publ) is a global diagnostics company specializing in near-patient, decentralized blood diagnostics and one of the few companies in the global diagnostics market …See details»
Boule Diagnostics AB (STU:8BD) Q3 2024 Earnings Call Highlights ...
Oct 28, 2024 Boule Diagnostics AB recognized 16 million in annual savings potential through extensive reorganization efforts. OEM sales showed strong performance, growing 51% in Q3 …See details»
Hematology Analyzer Market Future Prospects: Industry Size,
4 days ago • Boule Diagnostics AB • Bio-Rad Laboratories • Danaher Corporation ... Coherent Market Insights is a global market intelligence and consulting organization that provides …See details»
WHO prequalifies diagnostic test to support safer administration …
2 days ago On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to …See details»
Total quality concept - from insights to solutions - Boule
At Boule Diagnostics, ... Although Boules hematology analyzers are designed to be robust and require minimal maintenance, the service organization is a key factor for an overall high-quality …See details»
Investor Relations - Boule
Oct 16, 2024 Boule Diagnostics AB (publ) (“Boule”) uses cookies and similar technologies (jointly called “cookies”) which are text files placed on your computer, to collect standard …See details»